Skip to main content
. 2018 Jan 2;9(26):18594–18606. doi: 10.18632/oncotarget.23603

Figure 7. Scheme for the generation of OSKP-iPSC-Heps from aged donor-derived somatic cells.

Figure 7

Scheme illustrates the feasibility of generation of OSKP-iPSC-Heps from aged donor-derived somatic cells. Such iPSC-based cell therapy may provide better efficacy than senescent primary hepatocytes.